Psych Editorial
  • Home
  • Contact

Meet the Executive Eli Lilly and Company Leadership Team: Derica W. Rice

Meet the Executive Eli Lilly and Company Leadership Team: Derica W. Rice 

Derica W. Rice was promoted to executive vice president, global services and chief financial officer, effective January 1, 2010. He also is a member of the company’s executive committee. Prior to becoming Lilly’s CFO in 2006, Rice had been the vice president and controller since July 2003.

Born in Decatur, Alabama, he received a bachelor’s degree in electrical engineering from Kettering University (formerly the GMI Engineering & Management Institute) in 1988 and a master’s degree in business administration in 1990 from Indiana University.

Rice joined the company in 1990 as an international treasury associate. He held various assignments as a sales representative, manager of global financial planning and analysis for the medical devices division, and global planning manager for pharmaceuticals. In 1995, he became finance director and chief financial officer for Lilly Canada. In 1997, Rice was promoted to executive director and chief financial officer for European operations based in London. In 2000, he was the general manager of Lilly United Kingdom and Republic of Ireland.

In 2009, Rice was selected as one of the “Most Powerful Executives in Corporate America” by Black Enterprise magazine and he was selected as one of Diversity MBA magazine’s “Top 100 Under 50 Executives.” He serves as a member of the Board of Directors for Target Corporation, IU Health North and The Center for Leadership Development. He also serves as a member of the Indiana University Board of Trustees and the Board of Governors of the Indianapolis Museum of Art.

Source: Eli Lilly and Co. Press Releases – Executive Bios

Related Posts

Takeda Pharmaceuticals

Takeda and Lundbeck Announce FDA Approval of Brintellix™ (vortioxetine) for Treatment of Adults with Major Depressive Disorder

Eli Lilly and Co., Executive Bios

Meet the Executive Eli Lilly and Company Leadership Team: Fionnuala M. Walsh

Eli Lilly and Co., Executive Bios

Meet the Executive Eli Lilly and Company Leadership Team: Jacques Tapiero

News & Views

  • Now Accepting Content
  • Takeda and Lundbeck Announce FDA Approval of Brintellix™ (vortioxetine) for Treatment of Adults with Major Depressive Disorder
  • Introducing the New Kid on the Block to Treat Depression: “Brintellix”.
  • Meet the Executive Eli Lilly and Company Leadership Team: Fionnuala M. Walsh
  • Meet the Executive Eli Lilly and Company Leadership Team: Jacques Tapiero
Psych Editorial
Copyright © PhysicianEditorial.com
All Rights Reserved!